Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CaHA Injection for Facial Rejuvenation in Thai Patients
TCTR20251015002Phase 4Active, not recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Oct 2024
- Modality
- Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of calcium hydroxyapatite in facial volume loss, Rhytidosis facialis and cutaneous aging, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Primary endpoints: Efficacy of CaHA for facial rejuvenation and Safety of CaHA injection. Started Oct 2024; status: active, not recruiting.
02
Drugs
calcium hydroxyapatite
03
Conditions
facial volume lossRhytidosis facialiscutaneous aging
Beyond the preview
Go deeper on TCTR20251015002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251015002.